Read Time 29 minutes

Brain Age Test: What Stanford’s Young Brain Study Says About Your Lifespan

By John Smith. Reviewed by Jane Doe.

Key takeaways

  • One routine blood draw checks ~3,000 proteins and rates the biological age of 11 organ systems; the brain’s score shows the strongest tie to future disease and lifespan. 
  • An “old” brain triples Alzheimer’s risk compared with a normal one, and makes it roughly 12 times more likely than a youthful brain. 
  • Regular exercise, quality sleep, a plant-forward diet, and a cognitively active, socially engaged lifestyle all correlate with a younger brain profile. 

Overview

Your passport age and your brain’s real age can differ. Stanford researchers, after reading approximately 3,000 proteins from 45000 people, have demonstrated that a blood test can indicate whether your brain is considered “young” or “old.” An old brain raised the risk of death by 182% over 15 years, while a young one cut that risk by 40%. It also tripled the odds of Alzheimer’s disease. 

The research group believes this type of reading could transform medicine from a reactive to a preventive approach. Spot an aging brain years before memory slips, and you can trial exercise, diet, or drug tweaks while they still matter; the health-care version of tuning a car before it stalls.

What is a brain age test?

A brain age test estimates how fast your brain is aging by analysing proteins in a routine blood sample, not by checking how well you remember names.

It compares your protein “signature” to the average for people your age. If the pattern looks older than average, your brain is classed as biologically old; if younger, biologically young.

Unlike popular online quizzes that gauge mental agility, this test measures the biology of brain tissue itself. It treats proteins as wear-and-tear markers, much like mileage on a car’s odometer.

Often mistaken as the same, mental age and brain age differ from each other. A mental age test guesses how old your brain acts; a lab-based brain age test measures proteins in your blood to show your real biological age.

Key findings from the research

Stanford’s team analyzed blood samples from 44,498 adults aged 40-70 and used 3000 protein measurements to set a biological “clock” for 11 organs, ranging from the brain to fat tissue. The following are the highlights from the research:

  • The brain matters most: If your brain shows up as “old,” your chance of Alzheimer’s triples; show up as “young,” and the risk falls to about one-quarter of normal. 
  • Longevity link: An old brain raised the odds of dying in the next 15 years by about 2.8 times (182%), while a young brain cut that risk by 40%. 
  • Many people have mismatched organs: Roughly one-third of participants had at least one organ aging at a rate faster or slower than the rest of their body. 
  • Risk stacks up: The more “old” organs you carry, the higher the danger: two to four aged organs doubled the death risk, five to seven quadrupled it, and eight or more pushed it up eightfold. 

Why does knowing this technology matter?

Most brain disorders stay quiet for years. By the time memory slips or mood changes show up, the underlying damage has often spread too far for a full recovery. A multi-organ “age score” flips that script. By analyzing approximately 3,000 blood proteins, researchers can estimate the rate of decline in 11 organ systems long before symptoms appear. That early signal enables doctors to monitor high-risk organs more closely, shift patients onto proven lifestyle or medication regimens sooner, and assess whether these changes slow biological aging.

The score is also a clear yardstick. You can exercise, adjust your diet, and treat sleep issues, then retest in a year to see if your brain has moved toward a “younger” state, much like watching cholesterol levels drop after changing your diet. Researchers also benefit: they can identify high-risk volunteers more quickly, test new drugs more efficiently, and learn which habits truly keep brains resilient. In short, this technology turns longevity science into a practical dashboard, allowing you to track and improve it, rather than waiting for trouble to appear.

Worldwide, more than 57 million people live with dementia as of 2021 statistics, and that figure is projected to soar to 139 million by 2050. Alzheimer’s disease starts destroying brain tissue 20 years before the first memory slips appear, a long silent phase when preventive care could still work. Because a protein-based brain-age test can detect accelerated aging within this silent window, it offers an opportunity to intervene. At the same time, there’s still time to slow or even avert dementia’s progress.

The brain’s number is especially valuable. In the Stanford data, a biologically “old” brain predicted higher Alzheimer’s and mortality risk than any other single organ. Yet the same test also flags aging of the lungs, heart, kidneys, and immune system, providing a fuller picture of systemic health than any single marker. Knowing these scores turns longevity science into a practical dashboard that you can track and improve, rather than waiting for a disease to surface.

How do scientists measure brain age in blood?

Think of it as a lab check-up for your brain’s “wear and tear.” Here’s the simple flow:

  • One tube of blood: A high-throughput panel scans about 3,000 proteins floating in your plasma. Many of these proteins primarily originate from a single organ.
  • Protein fingerprint: A computer lines up the brain-linked proteins and compares your pattern with thousands of people the same age in the UK Biobank study.
  • Score against the average: If your brain’s protein mix sits 1.5 standard deviations above the norm, the test flags it as “old.” The same gap below the norm earns a “young” label.
  • Actionable number: You receive a brain-age readout (for example, “your brain looks 62 years old”). Doctors could repeat the test later to see if lifestyle or treatment changes move that number.

Note: The test is not yet clinic-ready. If it secures FDA clearance, it could become a routine part of preventive care. 

Why does the Stanford team say brain age matters most?

Your brain is the command hub for nearly everything your body does. It regulates heart rhythm and blood pressure through the autonomic nervous system, tunes hormone release via the hypothalamic-pituitary axis, encodes new memories, and integrates billions of sensory inputs into coherent decisions, all in real-time. When the cellular machinery that powers these tasks begins to age prematurely, every downstream system feels the strain. The blood-protein signatures in the Stanford study capture that strain with surprising precision, showing how a “biologically old” brain can ripple harm across the entire body. Among 11 organs, brain age showed the strongest link to both dementia and early death. Here’s more:

  • The “gatekeeper” effect: Stanford’s lead Scientist, Tony Wyss-Coray, calls the brain “the gatekeeper of longevity.” As your brain ages more slowly, you tend to live longer; conversely, when it ages rapidly, life expectancy decreases. 
  • Highest mortality signal: In the study, an “extremely aged” brain raised 15-year death risk by about 2.8 times (182%). No other single organ showed a stronger link to mortality. 
  • Stronger disease prediction: An old brain tripled Alzheimer’s risk compared with a normally aging one, and the gap widened to roughly 12 times when compared with a youthful brain. Other organs predicted their own diseases (old lungs → COPD, old heart → heart failure), but none matched the brain’s impact on both dementia and overall survival. 

In short, your brain’s biological age sends the clearest, strongest signal about how long you’re likely to stay healthy, which is why researchers rank it above every other organ in the protein-based test.

Simple habits that keep brains young

The same everyday choices that keep your heart fit, moving more, eating plants, sleeping well, avoiding tobacco, and staying socially active, also keep your brain’s protein “signature” looking younger. Add steady mental challenges and regular time with friends, and studies suggest you might push dementia back by about five years and cut your overall risk by roughly 38 percent.

HabitWhy it helpsEvidence
Move 30-45 min, 3-4 days a week (brisk walking, cycling, resistance work)Regular exercise stabilised thinking skills and slowed brain-volume loss in older adults at risk of Alzheimer’s.The Journal of Alzheimer’s Association
Follow a Mediterranean or MIND-style plate (vegetables, beans, fish, olive oil, nuts, berries)A 2025 meta-analysis linked these diets to fewer white-matter lesions — an MRI marker of brain aging and dementia.(BioMed Central)
Prioritise sleep (aim for 7-9 h and treat persistent insomnia)Middle-aged adults with three or more sleep problems showed brains ≈2.6 years older on MRI 15 years later.(PubMed)
Quit smoking (or never start)Pack-per-day exposure was a stronger driver of accelerated brain age than years smoked, shrinking brain volume faster than natural aging.Neurology
Layer good habits (exercise + healthy diet + social & cognitive engagement)In the 2025 U.S. POINTER trial, a two-year lifestyle program combining these elements improved overall cognition in 2,111 older adults.Journal of the American Medical Association

Limitations and future tests

Even clever studies have rough edges. Here’s what to keep in mind before taking the numbers at face value:

  • It’s not a clinic test yet: The protein panel is still a research tool. Doctors can’t order it, and no treatment guidelines use it.
  • One population, predominantly of European ancestry: Most volunteers were recruited from the UK Biobank. Results may shift in more diverse groups.
  • Associations, not guarantees: Hazard ratios indicate associations, not cause-and-effect relationships. An “old” brain score warns of a higher risk; it doesn’t mean you’ll get Alzheimer’s.
  • Protein levels can fluctuate: Illness, medication, or even a strenuous workout can alter blood-protein readings and compromise the age estimate.
  • Cost and complexity: Scanning ~3,000 proteins requires specialized equipment; prices must fall before routine check-ups become cost-effective.

What’s next

The science is promising, but it still needs real-world testing before your annual physical includes a “brain age” line item. Here are some possible next steps

  • Bigger, broader cohorts: Teams are already lining up US, Asian, and African data sets to see if the same signals hold.
  • Repeat testing over time: Tracking scores every year will show whether lifestyle changes or new drugs can “re-youth” an organ.
  • Slimmer panels: Researchers aim to reduce the assay to a few hundred key proteins, thereby reducing cost and turnaround time.
  • Head-to-head comparison with other clocks: Future work will assess the effectiveness of protein clocks in conjunction with DNA methylation and imaging tests to identify the most effective combination for early warning.
  • Clinical trials: If an intervention lowers brain-age scores, the next step is to demonstrate that it also reduces dementia and mortality rates.

Bottom line

Blood-protein testing can now flag a brain that’s aging faster than the calendar shows. In research so far, an “old” brain links to higher odds of Alzheimer’s and earlier death, while a “young” brain looks protective. The test isn’t ready for clinics yet, but it points to a future where doctors act long before symptoms start, and where social engagement and activities to occupy the brain stay your first line of defense.

Frequently Asked Questions (FAQs)

  1. Is a brain age test available at my doctor’s office?

Not yet. The assay is still a research tool. Stanford hopes for a simplified, clinic-ready version within two to three years.

  1. How is brain age different from mental age?

Brain age measures biological wear and tear inside brain tissue by analyzing blood proteins. Mental age quizzes assess thinking skills; they cannot indicate cellular aging.

  1. Can lifestyle changes reverse an “old” brain score?

The study found protein patterns shift with exercise, diet, and smoking status, suggesting improvement is possible, but formal trials are still underway.

  1. How often would I need to test?

Researchers expect that yearly or every-other-year checks will be sufficient to observe meaningful shifts once the test is commercialized.

  1. Will insurance cover it?

Coverage is uncertain. Insurers usually wait for FDA clearance and cost-effectiveness data before adding a new lab test to their plans.

References

  1. Oh, H. S. H., Le Guen, Y., Rappoport, N., Urey, D. Y., Farinas, A., Rutledge, J., … & Wyss-Coray, T. (2025). Plasma proteomics links brain and immune system aging with healthspan and longevity. Nature Medicine, 1-9.
  2. Baker, L. D., Espeland, M. A., Whitmer, R. A., Snyder, H. M., Leng, X., Lovato, L., … & Carrillo, M. C. (2025). Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial. JAMA.
  3. Lee, S., Garg, S., Datta, M., Nguyen, D., Akbari, N., Rajendran, A., … & Attariwala, R. (2024, April). Smoking Is Associated with Accelerated Brain Aging: A Large, Diverse Population-based Analysis (S43. 003). In Neurology (Vol. 102, No. 7_supplement_1, p. 2376). Hagerstown, MD: Lippincott Williams & Wilkins.
  4. Cavaillès, C., Dintica, C., Habes, M., Leng, Y., Carnethon, M. R., & Yaffe, K. (2024). Association of self-reported sleep characteristics with neuroimaging markers of brain aging years later in middle-aged adults. Neurology, 103(10), e209988.
  5. Wang, X., Xin, Z., Li, X., Wu, K., Wang, W., Guo, L., … & Lu, C. (2025). Mediterranean diet and dementia: MRI marker evidence from meta-analysis. European Journal of Medical Research, 30(1), 32.
Share
4 subscribe
Subscribe

RELATED CONTENT

Understanding heart age and its role in cardiovascular health
Heart Age and Cardiovascular Health: How to Stay Younger, Longer
More
How to age gracefully tips and supplements for vitality
How to Age Gracefully: Tips and Supplements for Vitality 
More
Dose coffee age you what science says about your daily brew
Does Coffee Age You? What Science Really Says About Your Daily Brew
More
How old is old exploring the perspectives on aging and subjective definitions of old age
How Old Is Old? Exploring the Perspectives on Aging and Subjective Definitions of Old Age
More

Longevity, Delivered to Your Inbox

Subscribe for curated research updates, practical tips, and the latest anti-aging breakthroughs

Subscription Form

Colton

Colton Qiu, PhD

Editor-in-Chief, Scientific Research

Colton is a regenerative medicine scientist with a focus on transfusion science, stem cell engineering, and platelet-based therapies. He earned his PhD in Medicine from Kyoto University’s Center for iPS Cell Research and Application (CiRA), the pioneering institute behind induced pluripotent stem cell (iPSC) technology. His research centered on improving the biomanufacturing process and long-term preservation of iPSC-derived platelets, advancing their applications in both transfusion medicine and next-generation PRP (platelet-rich plasma) therapies for tissue regeneration.

Beyond the lab, Colton is the co-founder and former president of the Japan–Taiwan Biotechnology Association (JTBA), where he played a pivotal role in establishing high-impact collaborations between academia, industry, and government to foster regenerative medicine innovation across Asia. He completed his doctoral training with the support of the Japan–Taiwan Exchange Association Scholarship, awarded for his outstanding contributions to cross-cultural scientific advancement.

Since completing his PhD, Colton has turned his focus toward the future of personalized healthcare. He firmly believes that science-backed strategies to delay aging and enhance healthspan already exist—but they must be tailored to each individual. Rejecting the idea of a “one-size-fits-all” solution, he advocates for making personalized longevity planning both scientifically rigorous and economically accessible. His mission is to help more people design evidence-based, customized pathways to healthier, longer lives.

Right down 2
Tristan

Tristan Yeung, MD

Editor-in-Chief, Medical Research

Tristan brings a distinctive perspective to longevity research through his integration of clinical medicine, translational research, and biomedical innovation. His MD from Harvard Medical School, combined with extensive engagement with Harvard Innovation Lab and HMS Makerspace, reflects his commitment to transforming scientific discoveries into practical interventions that can extend healthy human lifespan. His internal medicine internship at California Pacific Medical Center provides him with frontline clinical experience in treating age-related diseases, giving him intimate knowledge of how aging manifests in real patients and what interventions might have the greatest impact on healthspan extension.

Tristan’s translational research at Stanford’s Department of Radiology and Canary Center, where he implemented novel microRNA-encapsulated nanoparticle drug delivery systems for localized cancer treatment, demonstrates his expertise in cutting-edge therapeutic delivery mechanisms increasingly relevant to anti-aging interventions. His bioengineering background from Stanford University, where he developed a vitamin-eluting subdermal implantable rod for nutritional deficiencies as a Terman Engineering Scholar, showcases his innovative approach to sustained therapeutic delivery – a critical consideration for longevity interventions that must work over extended timeframes. Tristan’s unique combination of clinical training, research expertise, and entrepreneurial vision enables him to identify which longevity interventions hold promise for extending not just lifespan, but healthspan.

Right down 2
Jean cruz

Jean Cruz-Hernandez, PhD

Scientific Advisor

Jean Cruz (JC) combines deep scientific rigor with strategic vision as Global Managing Partner of AGMI, bringing a rare blend of bench science expertise and commercial acumen to longevity research analysis. His PhD in Biomedical Engineering from Cornell University, coupled with a postdoctoral fellowship and junior faculty position at Massachusetts General Hospital and Harvard Medical School, provides him with the technical depth needed to evaluate complex longevity interventions with scientific precision. JC’s pioneering work in neurodegenerative diagnostic and imaging platforms during his academic career gives him unique insight into one of aging’s most devastating aspects – cognitive decline, while his research that produced several US patents, over $5 million in sponsored grants, and publications in Nature demonstrates his ability to identify breakthrough approaches that could revolutionize how we understand aging processes. His specialized research initiatives focused on understanding aging-related neurological decline and developing therapeutic interventions position him at the forefront of one of longevity science’s most critical frontiers.

His extensive experience at McKinsey & Company, where he led strategic transformations for Fortune 500 pharma companies and conducted due diligence across oncology, neuroscience, and rare-disease portfolios, equips him to navigate the complex landscape of longevity research with both scientific rigor and commercial insight. JC’s work positions him to identify which approaches have genuine therapeutic potential versus those destined for clinical failure. JC brings unparalleled expertise in translating cutting-edge aging research into practical strategies that can extend healthy human aging.

Right down 2
Harvey

Yen-Po (Harvey) Chin, MD, PhD

Medical Advisor and Strategy Lead

Harvey brings a unique convergence of clinical medicine, bioinformatics, and advanced analytics to the pursuit of longevity science, combining deep scientific training with strategic vision to advance anti-aging research. His medical training from National Yang Ming Chiao Tung University and his PhD in Biomedical Informatics from Taipei Medical University, coupled with his postdoctoral Master of Biomedical Informatics from Harvard Medical School, positions him uniquely at the intersection where cutting-edge longevity research meets computational analysis and practical implementation. As a physician turned entrepreneur, Harvey understands both the clinical realities of aging-related diseases and the technological possibilities for intervention, giving him rare insight into how breakthrough biomedical innovations can translate from laboratory discoveries to meaningful patient outcomes.

As a Forbes 30 Under 30 honoree and Harvard Healthtech Innovation Fellow, Harvey has consistently identified and championed emerging technologies before they reach mainstream adoption, a skill directly applicable to the rapidly evolving field of longevity research. His experience as Executive Chairman of AGMI Group, where he has orchestrated over $1.5 billion in potential value through strategic partnerships in biopharma and advanced technology enterprises, demonstrates his ability to discern which medical interventions hold genuine therapeutic promise versus those destined for clinical failure. His frequent speaking engagements at Harvard, MIT, BIO Asia Conference, and Academia Sinica position him to stay at the forefront of longevity research developments as they emerge from the world’s leading institutions, while his commitment to developing the next generation of leaders through the AAC Talent Hub reflects his dedication to ensuring breakthrough anti-aging discoveries benefit future generations.

Right down 2

Longevity, Delivered to Your Inbox

Subscribe for curated research updates, practical tips, and the latest anti-aging breakthroughs

Subscription Form